Physician profile
Jacob Spinner
NPI 1356752018
$1,046.04
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $438 · 2020: $152 · 2021: $132 · 2022: $39.29 · 2023: $285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $285.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $172.93 | 2019-2023 | Jardiance, Spiriva Respimat, Stiolto Respimat |
| Allergan, INC. | $161.78 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $154.13 | 2019-2021 | |
| Pfizer INC. | $142.06 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $115.58 | 2019-2020 | |
| Abbvie INC. | $113.28 | 2021-2023 | Dalvance |
| Gilead Sciences, INC. | $78.29 | 2023 | Epclusa |
| Novartis Pharmaceuticals Corporation | $40.25 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $22.76 | 2021 | |
| Dexcom, INC. | $22.58 | 2021 | |
| Medtronic Vascular, INC. | $22.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Spinner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.